Sign in
FBRX Stock Price, Chart, Stats & News
Forte Biosciences, Inc.
Save
243.83M
Market cap
–
Current P/E
–
Forward P/E
FBRX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -53.29% |
ROE | -75.64% |
D/E | – |
Interest coverage ratio | – |
FBRX valuation
P/E | – |
P/S | – |
P/B | 5.40x |
P/CF | -10.21x |
P/FCF | -7.17x |
P/OCF | -10.21x |
PEG | -0.20x |
EV multiple | -7.87x |
About
Forte Biosciences, Inc. is a U. S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata.
Similar securities
Based on sector and market capitalization
Report issue